Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kymera Therapeutics (KYMR) Net Income (2019 - 2026)

Kymera Therapeutics (KYMR) has disclosed Net Income for 8 consecutive years, with -$84.2 million as the latest value for Q1 2026.

  • For Q1 2026, Net Income fell 13.04% year-over-year to -$84.2 million; the TTM value through Mar 2026 reached -$359.5 million, down 29.09%, while the annual FY2025 figure was -$349.8 million, 33.56% down from the prior year.
  • Net Income hit -$84.2 million in Q1 2026 for Kymera Therapeutics, up from -$98.0 million in the prior quarter.
  • Across five years, Net Income topped out at -$19.4 million in Q4 2023 and bottomed at -$98.0 million in Q4 2025.
  • Average Net Income over 5 years is -$60.2 million, with a median of -$57.6 million recorded in 2023.
  • Year-over-year, Net Income skyrocketed 49.95% in 2023 and then crashed 317.34% in 2024.
  • Kymera Therapeutics' Net Income stood at -$38.7 million in 2022, then skyrocketed by 49.95% to -$19.4 million in 2023, then plummeted by 317.34% to -$80.8 million in 2024, then decreased by 21.25% to -$98.0 million in 2025, then grew by 14.05% to -$84.2 million in 2026.
  • According to Business Quant data, Net Income over the past three periods came in at -$84.2 million, -$98.0 million, and -$92.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.